A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer (Q36612255)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 August 2006
edit
Language Label Description Also known as
English
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
scientific article published on 8 August 2006

    Statements

    A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer (English)
    G P Stathopoulos
    K Syrigos
    G Aravantinos
    A Polyzos
    P Papakotoulas
    A Potamianou
    N Ziras
    J Boukovinas
    J Varthalitis
    N Androulakis
    A Kotsakis
    G Samonis
    V Georgoulias
    8 August 2006
    587-592

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit